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T-tests and multivariate linear regression models were conducted to compare
cotinine levels between comparison groups.
Result: Males and females were equally represented, with a mean age of
45.8 yrs (SD=12.6 years). Cigarette smokers had significantly higher co-
tinine levels (1477.4±1602 ng/ml) than non-smokers (57.6±155.2 ng/ml,
p=0.02), and passive smokers (spouses of smokers) levels were intermedi-
ate (940.6±1719 ng/ml). Tobacco chewers had the highest cotinine levels of
all groups (2779.9±2591 ng/ml) and the significant difference persisted after
adjustment for age, sex, body mass index, and physical activity (p
Conclusion: This is one of the first studies evaluating cotinine levels for
smokeless tobacco in 24-hour urine samples in India. These findings require
replication and suggest that combating nicotine dependency in chewers may be
more difficult than in other tobacco users.
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ARE INDIANS SHIFTING FROM SMOKING TO SMOKELESS TOBACCO?
G.K. Mini 1, N.B. Sureshkumar2. 1Sree Chitra Tirunal Institute for Medical
Sciences and Technology, Trivandrum, India; 2State Resource Centre,
Trivandrum, India
Background: Smoking is the dominant form of tobacco globally. However in
Asian countries like China, India and Indonesia which share the maximum bur-
den of tobacco use, the use of smokeless form of tobacco is common. The
adverse health and economic effect of smokeless tobacco is as harmful as that
of smoking. In India, 75% of the tobacco users were smokeless tobacco users
(SLT). Limited information is available at the population level on smokeless
tobacco as a smoking cessation aid in India.
Objective: The present study examines the tobacco transition with specific em-
phasis on switching over to smokeless tobacco as a smoking cessation method
among adults in India.
Method: We used raw data on the nationally representative household survey
Global Adult Tobacco Survey (GATS) 2009–2010 India for the present study. We
studied the smoking cessation method for those who quit smoking within 1 year.
Result: Prevalence of smokeless tobacco was nearly two times higher than that
of smoking in India. The exclusive smokeless tobacco use was three time high
than that of smoking prevalence. Quit ratio was low among smokeless tobacco
users (5%) compared to smokers (13%). SLT use was more prevalent in rural
area (29%) compared to their urban counterparts (18%). Among former smokers
(ever-smokers who stopped smoking within one year) 20% switched to smokeless
tobacco as a smoking cessation method. Men were five times higher switching
to SLT than women (OR 4.81, 95% CI 4.76–4.87). Youth (15–24 years) (OR 1.59,
CI 1.57–1.60) educated (OR 4.14, CI 4.11–4.17) and employed (OR 10.8, CI
10.66–10.94) adults were more likely to switching to smokeless tobacco as a
smoking cessation aid.
Conclusion: The recent transition from smoking to smokeless tobacco use in
India is remarkable and relevant to the global discussion for further studies
and has implications for tobacco control policies in India. The low quit rate
among smokeless tobacco users and a high proportion of smokers switching to
smokeless tobacco predicts the future burden of SLT in India.
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A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE HEALTH EFFECTS OF
NON-SNUS SMOKELESS TOBACCO PRODUCTS
Sudhir Venkatesan1, Jo Leonardi-Bee1, Puja Myles 1, Ann McNeill 2.
1University of Nottingham, United Kingdom; 2King' s College London, United
Kingdom
Background: Previous reviews on the health effects of smokeless tobacco
have included Swedish snus, which is known to be less harmful than conven-
tional products, and preparations containing betel nut which is independently
carcinogenic.
Objective: This systematic review seeks to determine risk of oral squamous
cell carcinoma (OSCC), leukoplakia, periodontal disease, pancreatic cancer
and adverse foetal outcomes in users of non-snus smokeless tobacco products
(NSST).
Method: Systematic review and meta-analysis was conducted in accordance
with Meta-analysis of Observational Studies in Epidemiology (MOOSE) guide-
lines. Pooled odds ratios and 95% confidence intervals were estimated by
using random-effect models. We searched Medline, Embase and PsycInfo; no
language restrictions were imposed. The primary outcomes were OSCC, leuko-
plakia, periodontal disease, pancreatic cancer and adverse foetal outcomes.
All forms of smokeless tobacco from different countries, except snus and the
ones containing betel nut, were considered as exposures.
Result: A total of 25 studies from 7 different countries were included, of which
19 could be included in the meta-analysis. NSST was significantly associated
with an increased risk of leukoplakia (OR=13.46; 95% CI: 4.29 to 42.25; I2=98%)
and nearly doubled the risk of OSCC (OR=1.84; 95% CI: 0.83 to 4.07; I2=95%).
However, NSST use had no significant effect on the risk of pancreatic cancer
(OR=1.04; 95% CI: 0.47 to 2.32; I2=59%). Adverse fetal outcomes were only
considered in one study which found that NSST use during pregnancy decreased
mean birth weight of the infant by 17.1g (95% CI: 103 to 69). It was not possible
to calculate pooled estimates for studies considering periodontal disease due
to insufficient data.
Conclusion: NSST users are at significantly increased risk of OSCC and leuko-
plakia however no association was detected with pancreatic cancer. Few stud-
ies have been performed on other systemic diseases, in particular relating to
pregnancy outcomes. The findings of this meta-analysis reaffirm the vastly
heterogeneous nature of smokeless tobacco products around the world. Despite
the exclusion of potential confounding factors (South Asian products containing
betel nut) and products with markedly different manufacturing processes (snus
from Sweden), extreme levels of heterogeneity were observed which makes
it critical for future global research on smokeless tobacco to identify a firm
means of classifying and assimilating evidence on smokeless tobacco.
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SURVEILLANCE OF OTHER TOBACCO PRODUCT USE IN THE ASIA–PACIFIC
REGION: IMPLICATIONS FOR POLICY
S. Benjakul, P. Gupta, A.Z. Khan, M. Kashiwabara, S. Kosen, J.R. Rarick,
D.N. Sinha, H. Tee Guat Hiong, M. Zaman. WHO, Western Pacific Region Office
Background: The WHO South-East Asia and Western Pacific Regions have a
combined 680 million tobacco smokers, and within the South-East Asia Region
alone there are an additional 250 million smokeless tobacco users. Many coun-
tries have started to implement effective tobacco demand reduction measures.
However, as countries enforce smoke-free legislation, and raise tobacco taxes
(focussing in most cases on manufactured cigarettes) tobacco companies have
started to shift to marketing smokeless tobacco products and/or other forms of
tobacco not affected by the increase of prices.
Objectives: To describe prevalence of use, market-size, and cost of “other
tobacco products” relative to manufactured cigarettes in eight countries that
have conducted the Global Adult Tobacco Survey.
Methodology: This study examines findings from Global Adult Tobacco Surveys
conducted in eight countries (Bangladesh, China, India, Indonesia, Malaysia,
Philippines, Thailand, and Vietnam) to determine the prevalence of a variety
of other tobacco product use (defined and non-manufactured cigarettes). Re-
cent trends in market growth of other tobacco products, along with price and
taxation data, were also analysed where this information was available.
Results: While the types of other tobacco product use varies between coun-
tries, prevalence of use of these products represents a significant proportion
of overall tobacco use in several of the countries studied. Analyses of avail-
able tax data has shown that several of the products looked at were taxed at
significantly lower rates than manufactured cigarettes.
Conclusions: Other tobacco product use represents a significant portion of
the tobacco-related health burden in several countries in South-East Asia. The
findings of this study point to a need for improved surveillance to better identify
trends in the use of other tobacco products, and for policies to reduce demand
for these products.
The political landscape for the tobacco endgame
OP001
REGULATING INDUSTRY INTERFERENCE & WHO FCTC IMPLEMENTATION:
ARTICLE 5.3 & THE FUTURE OF GLOBAL HEALTH
Jeff Collin, Sarah Johnston, Evgeniya Plotnikova, Sarah Hill. University of
Edinburgh, United Kingdom
Background: Unlike other producers of unhealthy commodities, tobacco com-
panies are now widely viewed as vectors of disease, with whom partnership
approaches are recognised as unacceptable in policy and in science and from
whom voluntary initiatives are seen as inadequate. The fundamental conflict of
interest between the tobacco industry and health receives unique recognition
in Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC),
under which states must protect the development of public health policies from
tobacco industry interference. Yet the extent to which parties are committed
to implementing Article 5.3 can appear questionable.
Method: We examined FCTC implementation reports from 161 countries to
assess country perceptions of the extent of implementation of Article 5.3 and
of tobacco industry interference as a barrier to FCTC implementation.
Result: Overall, 54% of FCTC parties report having adopted and implemented
programmes to protect tobacco control policies from the vested interests of
the tobacco industry. This figure masks substantial variation when countries
are organized by World Bank income categories; only one third of low income
countries and under half of high income countries report implementing such
programmes. Variation is more pronounced across WHO regions; whereas al-
most three quarters of countries from the Eastern Mediterranean Region claim
to have implemented such measures, almost two thirds of the African Region
report no such progress. Fewer countries claim to have implemented measures
to ensure public access to information on industry activities; three quarters of
both low- and high-income countries report no such measures. Comments pro-
vided within the implementation reports suggest low compliance with specific
recommendations made in the implementation guidelines for Art. 5.3. Only
9 countries identified Art. 5.3 as a priority for further FCTC implementation,
while one fifth of parties identified tobacco industry interference and tactics
as barriers to implementation more broadly.
Conclusion: The successful implementation of Art. 5.3 is widely recognised
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as critical to the overall success of the FCTC, and the limited evidence of
active measures reported in these reports raise serious concerns. While issues
of resources and capacity might explain limited progress in much of the Global
South, the disappointing levels of implementation in high income countries
rather suggest limited political commitment. This is echoed by the limited
interpretation of Art. 5.3 that characterises some national tobacco control
plans. While Art. 5.3 is increasingly seen as a model that might be applicable
to other industries, this analysis shows that substantial work needs to be done
within tobacco control to consolidate this approach. Increasing policy interest
in harm reduction and innovative products may further hinder such progress.
OP007
LITIGATION, A KEY TO TOBACCO FREE WORLD: A REVIEW OF JUDICIAL
PRONOUNCEMENTS FROM INDIA
Deepti Singh, Amit Yadav. Public Health Foundation of India
Background: Law as an instrument of social transformation helps in creating
public awareness strengthens public policies and redresses injuries. The leg-
islature realized the hazardous effects of tobacco use which has resulted in
drafting of the pertinent tobacco control laws. The Judiciary has complemented
these legitimate goals of public health pronouncing tobacco control initiatives
as imperative to realization of fundamental right to life. The Supreme Court of
India in 2001 itself banned smoking in public places throughout the country and
since has upheld several tobacco control provisions under its domestic laws. Re-
cently health rights judgments from Australia, Latin America, Colombia, South
Africa, Argentina, Brazil & Canada strengthened tobacco control enforceability
and these judicial precedents have provided strength to the much awaited goal
of the endgame for tobacco.
Objective: This paper will present a review of the judicial pronouncements in
enforcing right to health as a concomitant part of the Indian constitution with
special reference to tobacco control litigations in India
Method: Review of primary sources such as Indian Tobacco Control Laws, the
Constitution of India and key tobacco control litigations from India and other
countries have been undertaken.
Result: The Courts in India have played a significant role in realization of the
right to health by recognizing it as a part of the fundamental right to life and
issued suitable directions to the state authorities for the fulfilment of their
duties. Similarly, for the effectiveness of tobacco control in India, judiciary has
come up with path breaking judgments from enforcing the ban on smoking in
public places to imposing a ban on sale of gutkha (smokeless) products across
the country and have paved the way for achieving the goal of a tobacco free
society.
Conclusion: This paper identifies series of judgments passed in public interest
and role of judiciary in progressive realization of the right to health. The
judiciary has played a vital role in enforcing tobacco control laws in India by
creating a promising scenario for successful implementation of stronger and
effective tobacco control measures.
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FCTC ARTICLE 5.3 & GOOD GOVERNANCE/ANTI-CORRUPTION MEASURES:
HOW TO ACCELERATE ARTICLE 5.3 IMPLEMENTATION
John Stewart, Cloe Franko. Corporate Accountability International, United
States
Background: Big Tobacco' s future hinges on its ability to interfere in public
health laws. The world' s first public health and corporate accountability treaty,
the Framework Convention on Tobacco Control (FCTC), includes a critical pro-
vision, Article 5.3, which states the tobacco industry has an irreconcilable
conflict of interest with public health.
Article 5.3 is already paying dividends for public health. However, its incor-
poration into national legislation has been slower than other FCTC articles, in
part because Article 5.3 is a good governance measure that limits corporate
interference in policymaking.
The tobacco control movement has spent decades devising a good governance
framework for tobacco products to regulate the industry and protect public
health policies from commercial interests.
The tobacco industry has a long history of corrupt conduct. Corruption in the
context of tobacco control ranges the gamut of tobacco industry interference
tactics fueling fraudulent conduct by those in power.
Objective:
1. Encourage policymakers and advocates to accelerate implementation of
Article 5.3 into national legislation.
2. Make the case that Article 5.3 and its guidelines can be considered anti-
corruption measures and that this comparison can be a powerful tool for
advocacy and to accelerate enforcement.
3. Share successful case studies and ideas for how to mobilize the anti-
corruption and transparency community.
Method: Survey of policymakers, tobacco control, transparency and anti-
corruption organizations, research of case studies of tobacco industry in-
terference that have used anti-corruption laws to challenge the industry and
policymakers that have violated Article 5.3 and research of existing anti-
corruption law and how it compares to Article 5.3 and its guidelines.
Result: Because the tobacco industry has a history of fomenting corrupt prac-
tices among policymakers, insulating public policymaking from tobacco industry
interference and increasing transparency is, in actually, an anti-corruption mea-
sure. This is precisely what Article 5.3 aims to do. Article 5.3 and its guidelines
can be incorporated into existing anti-corruption measures like codes of conduct
or enforcement mechanisms.
Conclusion: National anti-corruption laws present an opportunity to strengthen
the implementation and enforcement of Article 5.3 provisions. Anti-corruption
laws apply broadly to government officials across agencies to further public
health policy.
OP035
TOBACCO INDUSTRY DIVERSIFICATION IN AFRICA: STRATEGIES, ACTIVITIES
AND IMPLICATIONS
Mohamed Ould Sidi Mohamed, Kellen Nyamurung, Possy Mugyenyi. WHO –
Center for Tobacco Control (CTCA), Uganda
Background: Center for Tobacco Control (CTCA) has prepared this study on
tobacco industry (TI) for governments and other TC stakeholders in Africa
to provide a snapshot of the TI behavior in terms of common activities and
tactics, TI market share and progress on implementation of Article 5.3 of
FCTC. Furthermore, this report provides a comparison of TI actions and makes
recommendations on how to counter the TI Interference in the region.
The presentation gives the synthesis of findings from twelve (12) WHO-AFRO
country data collected using the TIM tool developed by CTCA. The main ob-
jective of this study is to provide a more comprehensive understanding of the
presence of the Tobacco Industry (TI) and its operations in Africa.
Objective: The objectives of this presentation
1. Identify the tobacco industry interference in AFRO region
2. Determine tobacco industries marketing strategies in Africa
3. Determine the range and target of industry activities and tactics
4. Identify corporate social responsibilities activities
5. Identify tobacco industries front groups
Method: The study used data from 12 countries using a semi-structured ques-
tionnaire based on the WHO-FCTC Article 5.3 and guideline. Specifically the
data collection tool focused on interference on legislation, tobacco production,
market share, and new tactics of the TI including TAPS, CSR, philanthropy,
alliances and front groups. The data collection took place from September 2012
to March 2013 and analysis focused on twelve countries and in the Africa region.
Data collection was done by Ministry of Health and Civil Society Organizations
involved in TC. The countries that participated in the study include: Benin,
Burkina Faso, Cameroon, Chad, Cote d' Ivoire, Ghana, Niger, Senegal, Angola,
Kenya, Mauritania and Uganda.
Results:
– Market share: three major trans-national tobacco companies operating in
these countries are British American Tobacco (BAT), Imperial Tobacco and
Philip Morris. BAT has a strong presence in Angola, Burkina Faso, Ghana,
Kenya, Senegal, and Uganda; while Imperial Tobacco has a strong presence
in Côte d' Ivoire, Burkina Faso and Chad, while Phillip Morris International is
in Senegal.
– Tactics and activities: the analysis shows a gradual move from use of giant
billboard to subtle but aggressive point of sale brand. The findings also show
that the TI is targeting children and the youth in their marketing.
– Implementation of Article 5.3: Some countries' view the TI as a partner,
source of a partner, source of revenue
OP038
ENDGAME FOR MENTHOL AND SLIM CIGARETTES IN EUROPE? POLAND –
THE LAST HURDLE
Mateusz Zygmunt Zatonski. Health Promotion Foundation, Poland
Background: In internal tobacco industry documents, menthol and “slim”
cigarettes appear as key products for enticing teenagers into smoking, and in
Japan, Finland, or Poland account for over 1/5 of the tobacco market share. In
December 2012 the EU Commission proposed to update the Tobacco Products
Directive, including a ban on the sale of flavoured and “slim” cigarettes (FaSCs)
in the EU. While the majority of EU countries support this proposal, the Polish
Ministry of Agriculture, urged by Polish tobacco growers and many MPs, has
called the government to block the update.
Objective: 1) Identify the key stakeholders among the Polish and EU bodies in-
volved in the discussion over the sale of FaSCs since December 2012. 2) Classify
their position, and assess their relative impact on the eventual outcome of the
debate.
Method: Qualitative analysis and synthesis of primary and secondary sources
released by the EU during the update' s formulation, and of sources documenting
the attitudes towards this proposal, e.g. EU Commission update proposal and
impact assessment, Eurobarometer survey on Europeans attitudes towards to-
bacco (May 2012), Euromonitor tobacco in Poland report (September 2012), and
documents analysing the impact of the update on Poland released by tobacco
companies, the pro-tobacco lobby, the anti-tobacco lobby, Polish governmental
agencies, and the reception of the update in the Polish parliament and media.
Result: Eight principal stakeholders were identified that could be grouped as:
public opinion (Polish citizens, media), lobbyists (pro-tobacco and pro-health
groups), political bodies (EU Commission, Polish Health Ministry, Polish Agri-
